Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
JCO Precision Oncology|February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research ExperienceAmelie Lier, Roland Penzel, Christoph Heining, et al.Nature|May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencingVolker Hovestadt, David T W Jones, Simone Picelli, et al.Nature Communications|May 10, 2022
The genomic and transcriptional landscape of primary central nervous system lymphomaJosefine Radke, Naveed Ishaque, Randi Koll, et al.European Journal of Cancer (Oxford, England : 1990)|August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyBarbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.Cancer Discovery|June 11, 2021
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersPeter Horak, Christoph Heining, Simon Kreutzfeldt, et al.Nature|December 6, 2019
The molecular landscape of ETMR at diagnosis and relapseSander Lambo, Susanne N Gröbner, Tobias Rausch, et al.Nature Genetics|July 3, 2013
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytomaDavid T W Jones, Barbara Hutter, Natalie Jäger, et al.Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.Nature|June 8, 2018
Author Correction: The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.Pageof 7